SCYNEXIS INC 8-K

What Happened
SCYNEXIS, Inc. filed a Certificate of Amendment to effect a one-for-eight (1:8) reverse stock split of its common stock and to reduce its authorized common shares, effective May 29, 2026. The reverse split and share reduction were approved by stockholders at a special meeting and by the Board on May 19, 2026; the amendment was filed with the Delaware Secretary of State on May 28, 2026. At the effective time, every eight outstanding shares were combined into one share, and the total authorized common shares were reduced from 150,000,000 to 18,750,000. SCYNEXIS’s common stock is scheduled to begin trading on a split-adjusted basis on the Nasdaq Capital Market at market open on June 1, 2026 under the existing ticker "SCYX." The new CUSIP for the post-split shares is 811292 309.

Key Details

• Reverse split ratio: 1-for-8 (every 8 shares → 1 share).
• Authorized common shares reduced from 150,000,000 to 18,750,000; par value remains $0.001 per share.
• Effective dates: amendment filed May 28, 2026; effective May 29, 2026; trading adjusted June 1, 2026.
• Equity awards (stock options, RSUs, warrants) were proportionally adjusted (fewer shares issuable, higher exercise prices); no fractional shares were issued—holders entitled to fractional shares will receive cash in lieu.

Why It Matters
A reverse stock split reduces the number of outstanding shares and increases the per-share price proportionately, but does not change any stockholder’s percentage ownership (except for cash-outs of fractional shares). The action also reduces the number of shares available for future issuance under equity plans and adjusts outstanding options/warrants and RSUs. Investors should note the trading will reflect the split starting June 1, 2026 and the company’s filing does not state a reason for the reverse split. Review your holdings for any cash-in-lieu payments for fractional shares and expect option/warrant terms to be recalculated on the 1:8 basis.